Baxter Belgium Manufacturing SA (manufacturing, primary and secondary packaging, GLP quality control, batch release)

The drug is used for replacement therapy in primary and secondary immunodeficiencies (when the body does not produce enough antibodies). It is also used for immunomodulation in conditions such as primary immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.

Dosage form: solution for infusion

ATC: J06BA02